Skip to main content

Currently Skimming:

Appendix E: Committee Member and Staff Biographies
Pages 301-318

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 301...
... (Chair) , is a professor of Medicine, Genetics, Public Health, and Computational Biology at the University of Michigan, where he also serves as director of the Center for Computational Medicine & Bioinformatics and the Proteomics Alliance for Cancer Research.
From page 302...
... He is currently assistant director for Biostatistics and Medical Informatics for the University of Wisconsin Institute for Clinical and Translational Research, funded in part by NIH. He has coauthored or edited four texts, including Fundamentals of Clinical Trials, now in its fourth edition, as well as texts on statistical methods for clinical trials, principles for data monitoring committees, and case studies for data monitoring.
From page 303...
... He is a fellow of the American Statistical Association, International Statistics Institute, Society for Clinical Trials, American Association for Medical Informatics, and American Association for the Advancement of Science. Thomas Fleming, Ph.D., is professor of Biostatistics and Statistics and a full member in the Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center.
From page 304...
... in 2011 as the Gordon Moore Endowed Chair, where he serves as chair of the Department of Biomedical Engineering, director of the OHSU Center for Spatial Systems Biomedicine, and associate director for Translational Cancer Research in the Knight Cancer Institute. He continues as a visiting
From page 305...
... Padnos Professor of Breast Cancer Research and a professor in the Department of Internal Medicine, Division of Hematology Oncology at the University of Michigan School of Medicine.
From page 306...
... Dr. Henderson serves on data monitoring committees for government- and industry-sponsored clinical trials; he also serves on scientific and medical advisory boards for organizations conducting technology assessments in health care.
From page 307...
... In 2001, he spent a year as a visiting scientist at the Fred Hutchinson Cancer Research Center and served on the faculty of the Department of Health Services. His current research focus in on cost-effectiveness and diagnostic value of medical technology in screening for cancer and other diseases.
From page 308...
... Harold Moses, M.D., is the director emeritus of the Vanderbilt-Ingram Cancer Center; Hortense B Ingram Professor of Molecular Oncology; professor of Cancer Biology, Medicine, and Pathology; and the founding and current director of the Frances Williams Preston Laboratories.
From page 309...
... Dr. Pao has received multiple honors and awards, including an American Society for Clinical Oncology Young Investigator Award, a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, a V Foundation grant, the Hope Now Award from the Joan's Legacy Foundation, and a Stand Up To Cancer Innovative Grant Award from the American Association for Cancer Research.
From page 310...
... Jude and the Bone Marrow Transplant Clinical Trials Network's Data Safety Monitoring Boards and a member of a Centers for Disease Control and Prevention's Institutional Review Board. She is coeditor of the ethics section of the Oncologist.
From page 311...
... Partners in Progress, and the Centers for Disease Control and Prevention, and is a member of the Intercultural Cancer Council and the External Advisory Board of the University of California, San Francisco Breast Cancer SPORE. She has served on the National Steering Committee for Redes En Acción: National Latino Cancer Research Network and was the team leader for the Insurance team for EDICT (Eliminating Disparities in Clinical Trials)
From page 312...
... Ransohoff extended his work in clinical epidemiology and diagnosis to include molecular markers for cancer and now collaborates with a number of National Cancer Institute groups, including the Early Detection Research Network and the Clinical Proteomic Technology Assessment for Cancer.
From page 313...
... She worked on other topics, including nanotechnology and oncology, access to routine vaccines under Medicare Part D, implementing colorectal cancer screening, and multi-site Phase III clinical trials and the National Cancer Institute Cooperative Groups. Prior to her work at the IOM, Dr.
From page 314...
... Her previous work at the IOM focused on topics that include developing cancer biomarkers, improving cancer clinical trials, formulating strategies for large-scale biomedical science, developing technologies for the early detection of breast cancer, improving breast imaging quality standards, assessing the impact of the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule on health research, and facilitating contraceptive research and development.
From page 315...
... Sarah Domnitz, Ph.D., was a Christine Mirzayan Science and Technology Policy Graduate Fellow with the Board on Health Care Services and the National Cancer Policy Forum. She received a Ph.D.
From page 316...
... She received her B.S. from Tufts University, graduating magna cum laude, and as an undergraduate was awarded a National Science Foundation Undergraduate Research Fellowship and a Lemelson Fellowship for Innovation at Hampshire College.
From page 317...
... From 2005 until 2009, Dr. Herdman directed the IOM National Cancer Policy Forum.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.